Description

LEVORID 5 MG

Indications

LEVORID 5 MG is primarily indicated for the treatment of allergic rhinitis, characterized by symptoms such as sneezing, runny or itchy nose, and itchy or watery eyes. It is also used in the management of chronic urticaria (hives) and other allergic conditions. The active ingredient in LEVORID, Levocetirizine dihydrochloride, is an antihistamine that helps alleviate the symptoms associated with these allergic reactions.

Mechanism of Action

Levocetirizine, the active component of LEVORID, is a selective antagonist of the peripheral H1 receptors. By blocking the action of histamine, a substance in the body that causes allergic symptoms, Levocetirizine effectively reduces the physiological responses associated with allergic reactions. This includes the inhibition of vasodilation, increased vascular permeability, and stimulation of sensory nerve endings, which are responsible for the typical symptoms of allergies.

Pharmacological Properties

LEVORID is characterized by its rapid onset of action, typically within one hour of administration, and its prolonged effect, lasting up to 24 hours. It is well-absorbed from the gastrointestinal tract, with peak plasma concentrations reached within approximately 1 hour. Levocetirizine exhibits linear pharmacokinetics, and its elimination half-life is approximately 8 to 9 hours. The drug is primarily excreted through the kidneys, with about 85% of the dose eliminated as unchanged drug in urine.

Contraindications

LEVORID 5 MG is contraindicated in patients with a known hypersensitivity to Levocetirizine, cetirizine, or any of the excipients in the formulation. It should also be avoided in individuals with severe renal impairment (creatinine clearance < 10 mL/min) due to the increased risk of accumulation and potential toxicity. Caution is advised when considering the use of this medication in patients with a history of urinary retention or bladder neck obstruction.

Side Effects

Common side effects associated with LEVORID include drowsiness, fatigue, dry mouth, and dizziness. While these side effects are generally mild and transient, some individuals may experience more severe reactions such as allergic reactions, including rash, itching, or swelling. In rare cases, Levocetirizine may cause serious side effects such as difficulty breathing, swelling of the face, lips, or tongue, and severe dizziness. Patients should be advised to seek immediate medical attention if any severe side effects occur.

Dosage and Administration

The recommended dosage of LEVORID 5 MG for adults and children over 12 years of age is one tablet taken once daily. For children aged 6 to 11 years, the recommended dose is half a tablet (2.5 MG) once daily. It is advisable to take the medication in the evening to minimize the impact of drowsiness. LEVORID can be taken with or without food. In patients with renal impairment, dosage adjustments may be necessary, and it is recommended to consult a healthcare provider for individualized dosing.

Interactions

LEVORID may interact with other medications, particularly those that cause sedation, such as benzodiazepines, opioids, and alcohol. Concurrent use of these substances can enhance the sedative effects of Levocetirizine, leading to increased drowsiness and impaired cognitive function. Additionally, caution should be exercised when using LEVORID with other antihistamines or medications that affect the central nervous system. It is important for patients to inform their healthcare provider of all medications they are taking to avoid potential interactions.

Precautions

Patients should use LEVORID with caution if they have a history of epilepsy or seizures, as it may lower the seizure threshold. Additionally, individuals with liver impairment should be monitored closely, as Levocetirizine is primarily eliminated by the kidneys. It is advised that patients avoid engaging in activities requiring mental alertness, such as driving or operating heavy machinery, until they know how LEVORID affects them. Pregnant and breastfeeding women should consult their healthcare provider before using this medication to assess the potential risks and benefits.

Clinical Studies

Clinical studies have demonstrated the efficacy of Levocetirizine in reducing symptoms of allergic rhinitis and chronic urticaria. In randomized, double-blind, placebo-controlled trials, patients receiving Levocetirizine reported significant improvement in nasal congestion, sneezing, and itching compared to those receiving a placebo. Additionally, studies have shown that Levocetirizine has a favorable safety profile, with a lower incidence of sedation compared to first-generation antihistamines. These findings support the use of LEVORID as a safe and effective option for managing allergic conditions.

Conclusion

LEVORID 5 MG, containing Levocetirizine, is an effective antihistamine for the treatment of allergic rhinitis and chronic urticaria. Its rapid onset of action and prolonged duration of effect make it a preferred choice for patients seeking relief from allergy symptoms. While generally well-tolerated, it is important for patients to be aware of potential side effects and interactions with other medications. Proper dosage and administration, along with precautions for specific patient populations, can help ensure safe and effective use of LEVORID.